Related references
Note: Only part of the references are listed.Discovery of thiosemicarbazone derivatives as effective New Delhi metallo-beta-lactamase-1 (NDM-1) inhibitors against NDM-1 producing clinical isolates
Bing Zhao et al.
ACTA PHARMACEUTICA SINICA B (2021)
Recent advances in the medicinal chemistry of carbonic anhydrase inhibitors
Shubham Kumar et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2021)
The roles of adenosine deaminase in autoimmune diseases
Zhao-wei Gao et al.
AUTOIMMUNITY REVIEWS (2021)
AncPhore: A versatile tool for anchor pharmacophore steered drug discovery with applications in discovery of new inhibitors targeting metallo-β-lactamases and indoleamine/tryptophan 2,3-dioxygenases
Qingqing Dai et al.
ACTA PHARMACEUTICA SINICA B (2021)
Design, synthesis, and biological evaluation of tetrahydroisoquinolines derivatives as novel, selective PDE4 inhibitors for antipsoriasis treatment
Rui Zhang et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2021)
Proteases and Their Modulators in Cancer Therapy: Challenges and Opportunities
Rao Song et al.
JOURNAL OF MEDICINAL CHEMISTRY (2021)
Discovery of Ethyl Ketone-Based Highly Selective HDACs 1, 2, 3 Inhibitors for HIV Latency Reactivation with Minimum Cellular Potency Serum Shift and Reduced hERG Activity
Wensheng Yu et al.
JOURNAL OF MEDICINAL CHEMISTRY (2021)
Discovery of GLPG1972/S201086, a Potent, Selective, and Orally Bioavailable ADAMTS-5 Inhibitor for the Treatment of Osteoarthritis
Franck Brebion et al.
JOURNAL OF MEDICINAL CHEMISTRY (2021)
Discovery of 3-aryl substituted benzoxaboroles as broad-spectrum inhibitors of serine- and metallo-8-lactamases
Yu-Hang Yan et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2021)
COVID-19: Zinc and Angiotensin-Converting Enzyme 2 (ACE2) Deficiencies as Determinants of Risk and Severity of Disease: A Narrative Review
Miklos P. Salgo
INFECTIOUS DISEASES AND THERAPY (2021)
Discovery of Taniborbactam (VNRX-5133): A Broad-Spectrum Serine- and Metallo-β-lactamase Inhibitor for Carbapenem-Resistant Bacterial Infections
Bin Liu et al.
JOURNAL OF MEDICINAL CHEMISTRY (2020)
Principles and current strategies targeting metallo-β-lactamase mediated antibacterial resistance
Yu-Hang Yan et al.
MEDICINAL RESEARCH REVIEWS (2020)
Advances in the Development of Phosphodiesterase-4 Inhibitors
Ting Peng et al.
JOURNAL OF MEDICINAL CHEMISTRY (2020)
Discovery of Cyclic Boronic Acid QPX7728, an Ultrabroad-Spectrum Inhibitor of Serine and Metallo-β-lactamases
Scott J. Hecker et al.
JOURNAL OF MEDICINAL CHEMISTRY (2020)
COVID-19: Drug Targets and Potential Treatments
Carmen Gil et al.
JOURNAL OF MEDICINAL CHEMISTRY (2020)
Inhibitors of SARS-CoV-2 Entry: Current and Future Opportunities
Siyu Xiu et al.
JOURNAL OF MEDICINAL CHEMISTRY (2020)
Thirty Years of HDAC Inhibitors: 2020 Insight and Hindsight
Terence C. S. Ho et al.
JOURNAL OF MEDICINAL CHEMISTRY (2020)
Catch and Anchor Approach To Combat Both Toxicity and Longevity of Botulinum Toxin A
Lucy Lin et al.
JOURNAL OF MEDICINAL CHEMISTRY (2020)
Targeting Metalloenzymes for Therapeutic Intervention
Allie Y. Chen et al.
CHEMICAL REVIEWS (2019)
Doxycycline reduces MMP-2 activity and inhibits invasion of 12Z epithelial endometriotic cells as well as MMP-2 and-9 activity in primary endometriotic stromal cells in vitro
Eleftherios P. Samartzis et al.
REPRODUCTIVE BIOLOGY AND ENDOCRINOLOGY (2019)
The carbonic anhydrase IX inhibitor SLC-0111 sensitises cancer cells to conventional chemotherapy
Elena Andreucci et al.
JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY (2019)
Recent advances in understanding the roles of matrix metalloproteinases in tumour invasion and metastasis
Guy A. Conlon et al.
JOURNAL OF PATHOLOGY (2019)
Probing the Interaction of Aspergillomarasmine A with Metallo-beta-lactamases NDM-1, VIM-2, and IMP-7
Alexander Bergstrom et al.
ACS INFECTIOUS DISEASES (2018)
Are Carbonic Anhydrases Suitable Targets to Fight Protozoan Parasitic Diseases?
Katia D'Ambrosio et al.
CURRENT MEDICINAL CHEMISTRY (2018)
In Silico Fragment-Based Design Identifies Subfamily B1 Metallo-β-lactamase Inhibitors
Ricky Cain et al.
JOURNAL OF MEDICINAL CHEMISTRY (2018)
Adenosine deaminase deficiency: a review
Aisling M. Flinn et al.
ORPHANET JOURNAL OF RARE DISEASES (2018)
Metallo-β-lactamase inhibitors by bioisosteric replacement: Preparation, activity and binding
Susann Skagseth et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2017)
Riding the metalloproteinase roller coaster
Gillian Murphy
JOURNAL OF BIOLOGICAL CHEMISTRY (2017)
Adenosine Deaminase (ADA)-Deficient Severe Combined Immune Deficiency (SCID): Molecular Pathogenesis and Clinical Manifestations
Kathryn L. Bradford et al.
JOURNAL OF CLINICAL IMMUNOLOGY (2017)
Newly Designed Quinolinol Inhibitors Mitigate the Effects of Botulinum Neurotoxin A in Enzymatic, Cell-Based, and ex Vivo Assays
Paul T. Bremer et al.
JOURNAL OF MEDICINAL CHEMISTRY (2017)
New tricks for human farnesyltransferase inhibitor: cancer and beyond
Jingyuan Wang et al.
MEDCHEMCOMM (2017)
Extracellular sphingomyelinase activity impairs TNF-α-induced endothelial cell death via ADAM17 activation and TNF receptor 1 shedding
Anselm Sommer et al.
ONCOTARGET (2017)
Targeting Adenosine Receptors for the Treatment of Cardiac Fibrosis
Elizabeth A. Vecchio et al.
FRONTIERS IN PHARMACOLOGY (2017)
Progress in the Discovery of Macrocyclic Histone Deacetylase Inhibitors for the Treatment of Cancer
Kai Cheng et al.
CURRENT MEDICINAL CHEMISTRY (2017)
Modifications of flexible nonyl chain and nucleobase head group of (+)-erythro-9-(2′s-hydroxy-3′s-nonyl)adenine [(+)-EHNA] as adenosine deaminase inhibitors
Sachin R. Kandalkar et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2017)
Metalloprotein Inhibitors for the Treatment of Human Diseases
Yang Yang et al.
CURRENT TOPICS IN MEDICINAL CHEMISTRY (2016)
Selective Histone Deacetylase Inhibitors with Anticancer Activity
Nan Ma et al.
CURRENT TOPICS IN MEDICINAL CHEMISTRY (2016)
B1-Metallo-beta-Lactamases: Where Do We Stand?
Maria F. Mojica et al.
CURRENT DRUG TARGETS (2016)
Inhibitors of the Metalloproteinase Anthrax Lethal Factor
Allison B. Goldberg et al.
CURRENT TOPICS IN MEDICINAL CHEMISTRY (2016)
A Disintegrin and Metalloprotease (ADAM): Historical Overview of Their Functions
Nives Giebeler et al.
TOXINS (2016)
How the flexibility of human histone deacetylases influences ligand binding: an overview
Nathalie Deschamps et al.
DRUG DISCOVERY TODAY (2015)
Histone deacetylases: structural determinants of inhibitor selectivity
Carmina Micelli et al.
DRUG DISCOVERY TODAY (2015)
The Recent Development of Farnesyltransferase Inhibitors as Anticancer and Antimalarial Agents
Yan Shen et al.
MINI-REVIEWS IN MEDICINAL CHEMISTRY (2015)
The Cambridge Structural Database in Retrospect and Prospect
Colin R. Groom et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2014)
Anthrax Lethal Factor Inhibitors as Potential Countermeasure of the Infection
B. V. S. Suneel Kumar et al.
CURRENT TOPICS IN MEDICINAL CHEMISTRY (2014)
Is there new hope for therapeutic matrix metalloproteinase inhibition?
Roosmarijn E. Vandenbroucke et al.
NATURE REVIEWS DRUG DISCOVERY (2014)
Metallo-beta-lactamase structure and function
Timothy Palzkill
ANTIMICROBIAL THERAPEUTICS REVIEWS: THE BACTERIAL CELL WALL AS AN ANTIMICROBIAL TARGET (2013)
Tasquinimod Is an Allosteric Modulator of HDAC4 Survival Signaling within the Compromised Cancer Microenvironment
John T. Isaacs et al.
CANCER RESEARCH (2013)
Angiotensin Converting Enzyme Inhibitors and the Reduced Risk of Alzheimer's Disease in the Absence of Apolipoprotein E4 Allele
Wei Qiao Qiu et al.
JOURNAL OF ALZHEIMERS DISEASE (2013)
Selective class IIa histone deacetylase inhibition via a nonchelating zinc-binding group
Mercedes Lobera et al.
NATURE CHEMICAL BIOLOGY (2013)
C-Terminus of Botulinum A Protease Has Profound and Unanticipated Kinetic Consequences upon the Catalytic Cleft
Peter Silhar et al.
ACS MEDICINAL CHEMISTRY LETTERS (2013)
Zinc Biochemistry: From a Single Zinc Enzyme to a Key Element of Life
Wolfgang Maret
ADVANCES IN NUTRITION (2013)
Adenosine Deaminase in the Modulation of Immune System and its Potential as a Novel Target for Treatment of Inflammatory Disorders
Luca Antonioli et al.
CURRENT DRUG TARGETS (2012)
Boron-based phosphodiesterase inhibitors show novel binding of boron to PDE4 bimetal center
Yvonne R. Freund et al.
FEBS LETTERS (2012)
New perspectives of zinc coordination environments in proteins
Wolfgang Maret
JOURNAL OF INORGANIC BIOCHEMISTRY (2012)
Discovery of Highly Potent and Selective Small Molecule ADAMTS-5 Inhibitors That Inhibit Human Cartilage Degradation via Encoded Library Technology (ELT)
Hongfeng Deng et al.
JOURNAL OF MEDICINAL CHEMISTRY (2012)
Human HDAC isoform selectivity achieved via exploitation of the acetate release channel with structurally unique small molecule inhibitors
Lewis Whitehead et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2011)
The design and synthesis of novel N-hydroxyformamide inhibitors of ADAM-TS4 for the treatment of osteoarthritis
Chris De Savi et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2011)
Purine and Pyrimidine Pathways as Targets in Plasmodium falciparum
Maria Belen Cassera et al.
CURRENT TOPICS IN MEDICINAL CHEMISTRY (2011)
Discovery of (1S,2R,3R)-2,3-Dimethyl-2-phenyl-1-sulfamidocyclopropanecarboxylates: Novel and Highly Selective Aggrecanase Inhibitors
Makoto Shiozaki et al.
JOURNAL OF MEDICINAL CHEMISTRY (2011)
Synthesis of Fluorinated Purine and 1-Deazapurine Glycosides as Potential Inhibitors of Adenosine Deaminase
Viktor O. Iaroshenko et al.
JOURNAL OF ORGANIC CHEMISTRY (2011)
Active Metalloproteases of the A Disintegrin And Metalloprotease (ADAM) Family: Biological Function and Structure
Theo Klein et al.
JOURNAL OF PROTEOME RESEARCH (2011)
Metallo-β-lactamases: a last frontier for β-lactams?
Giuseppe Cornaglia et al.
LANCET INFECTIOUS DISEASES (2011)
Elevated aggrecanase activity in a rat model of joint injury is attenuated by an aggrecanase specific inhibitor
P. S. Chockalingam et al.
OSTEOARTHRITIS AND CARTILAGE (2011)
A structural view of the antibiotic degradation enzyme NDM-1 from a superbug
Yu Guo et al.
PROTEIN & CELL (2011)
Botulinum Neurotoxin: A Marvel of Protein Design
Mauricio Montal
ANNUAL REVIEW OF BIOCHEMISTRY, VOL 79 (2010)
Biaryl substituted hydantoin compounds as TACE inhibitors
Wensheng Yu et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2010)
Reinventing the ACE inhibitors: some old and new implications of ACE inhibition
Kashif Hanif et al.
HYPERTENSION RESEARCH (2010)
Coordination Dynamics of Zinc in Proteins
Wolfgang Maret et al.
CHEMICAL REVIEWS (2009)
Selective Use of ADAM10 and ADAM17 in Activation of Notch1 Signaling
Esra Cagavi Bozkulak et al.
MOLECULAR AND CELLULAR BIOLOGY (2009)
The ADAM metalloproteinases
Dylan R. Edwards et al.
MOLECULAR ASPECTS OF MEDICINE (2008)
Carbonic anhydrases: novel therapeutic applications for inhibitors and activators
Claudiu T. Supuran
NATURE REVIEWS DRUG DISCOVERY (2008)
Drug insight: tumor necrosis factor-converting enzyme as a pharmaceutical target for rheumatoid arthritis
Marcia L. Moss et al.
NATURE CLINICAL PRACTICE RHEUMATOLOGY (2008)
Synthesis of 5′-methylthio coformycins:: Specific inhibitors for malarial adenosine deaminase
Peter C. Tyler et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2007)
ADAMs in cancer cell proliferation and progression
Satsuki Mochizuki et al.
CANCER SCIENCE (2007)
Selective inhibition of ADAM metalloproteases as a novel approach for modulating ErbB pathways in cancer
Jordan S. Fridman et al.
CLINICAL CANCER RESEARCH (2007)
Zinc through the three domains of life
Claudia Andreini et al.
JOURNAL OF PROTEOME RESEARCH (2006)
Identification of a potent botulinum neurotoxin a protease inhibitor using in situ lead identification chemistry
GE Boldt et al.
ORGANIC LETTERS (2006)
Anti-inflammatory activity of non-nucleoside adenosine deaminase inhibitor FR234938
M Kuno et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2006)
Counting the zinc-proteins encoded in the human genome
C Andreini et al.
JOURNAL OF PROTEOME RESEARCH (2006)
Botulinal neurotoxins:: revival of an old killer
C Montecucco et al.
CURRENT OPINION IN PHARMACOLOGY (2005)
Phosphodiesterase: overview of protein structures, potential therapeutic applications and recent progress in drug development
YH Jeon et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2005)
Anthrax lethal factor inhibition
WL Shoop et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Metalloproteinase inhibitors for the disintegrin-like metalloproteinases ADAM10 and ADAM17 that differentially block constitutive and phorbol ester-inducible shedding of cell surface molecules
A Ludwig et al.
COMBINATORIAL CHEMISTRY & HIGH THROUGHPUT SCREENING (2005)
Structural basis for the activity of drugs that inhibit phosphodiesterases
GL Card et al.
STRUCTURE (2004)
ADAMs family members as amyloid precursor protein α-secretases
TMJ Allinson et al.
JOURNAL OF NEUROSCIENCE RESEARCH (2003)
Discovery of γ-lactam hydroxamic acids as selective inhibitors of tumor necrosis factor α converting enzyme:: Design, synthesis, and structure-activity relationships
JJW Duan et al.
JOURNAL OF MEDICINAL CHEMISTRY (2002)
Crystal structure of the anthrax lethal factor
AD Pannifer et al.
NATURE (2001)
Function and mechanism of zinc metalloenzymes
KA McCall et al.
JOURNAL OF NUTRITION (2000)
Mechanistic studies of rat protein farnesyltransferase indicate an associative transition state
CC Huang et al.
BIOCHEMISTRY (2000)
Share Paper
